AFAIK - There is no “learning” with Control-IQ. It is not going to bolus you at 6AM because yesterday you did this, that or the next thing. It is not going to kick you out of auto mode because of whatever. It is a different approach. There has been a lot of information already released and some of the people involved in the clinical trial have spoken about Control-IQ. So far, there is zero indication that it operates in any way like the Medtronic approach.
If you are going high and out of range, it will deliver combination of basal and bolus increases. When you are predicted to be going low, it will reduce basal and perhaps suspend. Whereas Basal-IQ (the currently released algorithm) has the basal rate either on or off, the Control-IQ (not yet released) can modulate the basal. When you are running within range then your normal bolus and basal profiles will be in effect. Obvious question is the definition of “in range”. From what I heard, the low target is 112 non-adjustable (save for exercise mode that I think bumps the low up to 150 maybe?)
For us, Basal-IQ works so well right now that I am (at this point) not convinced that our current solution is not superior (for us) to the Control-IQ approach.
Running straight and level through the night at 80 is amazing. Right now, that is what Basal-IQ does for us.
I do expect that for a given pump, once the update for Control-IQ is applied that the Basal-IQ algorithm will be removed and further that the update is non-reversible for the consumer. At this point, I am not willing to give up our Basal-IQ algorithm.